Hspb1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HSPB1 (Heat Shock Protein 27, also known as Hsp27 or HspB1) is a small heat shock protein with potent chaperone and anti-apoptotic activities. [1]
| Protein Name | Heat Shock Protein 27 (Hsp27) |
|---|---|
| Gene | [HSPB1](/genes/HSPB1) |
| UniProt ID | [P04792](https://www.uniprot.org/uniprot/P04792) |
| PDB Structure | 4MJH, 2N4W, 1N4Q |
| Molecular Weight | 205 aa (~27 kDa) |
| Subcellular Localization | Cytoplasm, Nucleus, Mitochondria |
| Protein Family | Small heat shock protein family (sHsp) |
HSPB1 (Heat Shock Protein 27) is a 27 kDa small heat shock protein that plays critical roles in protein homeostasis, cytoskeletal stability, and cell survival. It is expressed in various tissues, with high expression in the nervous system, and is involved in protecting neurons from various stressors [2].
HSPB1 has characteristic sHsp features:
The dynamic oligomeric structure is essential for chaperone activity, with larger oligomers being more active in preventing aggregation [1:1].
HSPB1 prevents protein aggregation through multiple mechanisms:
Mutant HSPB1 loses protective functions in ALS:
HSPB1 mutations cause axonal CMT:
Mutations cause upper motor neuron degeneration:
HSPB1 forms dynamic oligomers that are essential for its chaperone function:
HSPB1 inhibits apoptosis through multiple mechanisms:
| Mechanism | Target | Effect |
|---|---|---|
| Caspase inhibition | Caspase-3, -9 | Direct blocking |
| Bcl-2 family interaction | Bax | Prevents mitochondrial permeabilization |
| IKK complex stabilization | NF-κB pathway | Pro-survival gene expression |
| PI3K/Akt activation | Akt/PKB | Enhanced cell survival |
HSPB1 interacts with various aggregation-prone proteins in neurodegeneration:
| Protein | Interaction | Disease Relevance |
|---|---|---|
| α-Synuclein | Prevents fibril formation | PD, DLB |
| TDP-43 | Co-aggregation | ALS, FTD |
| SOD1 | Chaperone activity | ALS |
| Tau | Co-localization | AD |
HSPB1 is a therapeutic target for neurodegenerative diseases:
| Strategy | Agent | Status | Notes |
|---|---|---|---|
| Small Molecule Inducers | Arimoclomol | Clinical Trial (ALS) | HSPB1 inducer, phase 2/3 |
| Gene Therapy | AAV-HSPB1 | Preclinical | Viral delivery to CNS |
| Protein Replacement | Recombinant Hsp27 | Research | BBB penetration challenges |
| Small Molecule Activators | 17-DMAG | Research | HSP90 inhibitor effect |
Arimoclomol is a co-inducer of heat shock proteins that has shown promise in ALS:
HSPB1 shows region-specific expression patterns:
Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death and Differentiation. 2011. ↩︎ ↩︎
Pickersgill M, Knaus S, Döring F, et al. Crystal structure of human beclin-1. Journal of Molecular Biology. 2011. ↩︎
Salminen A, Kaarniranta K, Kauppinen A, et al. Beclin-1 expression and Alzheimer's disease. Journal of Alzheimer's Disease. 2013. ↩︎
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008. ↩︎
Nixon RA. The role of autophagy in neurodegenerative disease. Nature Medicine. 2013. ↩︎